PCAT1 and hepatocellular carcinoma: In animal studies, the inhibition of PCAT-1 expression has proven effective as a tool to diminish tumor development across multiple cancer disorders including colorectal cancer, lung cancer, hepatocellular carcinoma, and squamous cell carcinoma [10].